The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
We formerly measured therapeutic rapport. We do it even with just a single item, a visual analog scale item, a subjective rating scale item on the morning of dosing, and we find that it's a significant predictor of the quality of the experience that you have under the drug in the psychedelic therapy, and then the therapeutic outcomes x weeks or months later.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.